First things first: an elderly woman in China, who became seriously ill after getting infected with the COVID-19 virus, made an uneventful recovery following stem cell therapy. Similar treatments were undertaken elsewhere — the outcome was reassuring. However, the fact is — it is early days in the chronicle of stem cells foretold.
The fact is lung and respiratory tract inflammation, during flu, for example, may be repaired by the immuno-modulatory effects of stem cells. This is primarily because stem cells mediate antiviral and antibacterial effects owing to the galvanisation of the body’s immune system. Be that as it may, the downside, perforce, is — the possibility of recurrence of the viral illness in stem cell-treated patients, especially when the virus is quiescent.
Patients with chronic disease — more so, when there is a limited, or no, treatment option — are progressively turning to stem cell therapy with the hope of a cure. Coronavirus is no exception. The possibility not only provides stem cell therapy a short in the arm, but also tangible, therapeutic optimism — although it is too premature to hoist the therapeutic pennant for stem cell therapy in COVID-19.
-30-
Copyright©Madras Courier, All Rights Reserved. You may share using our article tools. Please don't cut articles from madrascourier.com and redistribute by email, post to the web, mobile phone or social media.Please send in your feed back and comments to editor@madrascourier.com
